Equities

Rigel Pharmaceuticals Inc

Rigel Pharmaceuticals Inc

Actions
Health CarePharmaceuticals and Biotechnology
  • Price (USD)25.45
  • Today's Change0.41 / 1.64%
  • Shares traded2.36k
  • 1 Year change+167.87%
  • Beta1.0964
Data delayed at least 15 minutes, as of Nov 22 2024 14:36 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Key statistics

As of last trade Rigel Pharmaceuticals Inc (RIGL:NSQ) traded at 25.45, -14.65% below its 52-week high of 29.82, set on Nov 12, 2024.
52-week range
Today
7.48Jul 05 202429.82Nov 12 2024
Short selling activity
Low
Med
High
Provided by S&P Global Market Intelligence
Open25.34
High25.45
Low25.34
Bid25.09
Offer25.50
Previous close25.04
Average volume378.57k
Shares outstanding17.62m
Free float17.23m
P/E (TTM)115.56
Market cap441.08m USD
EPS (TTM)0.2167
USD
Data delayed at least 15 minutes, as of Nov 22 2024 14:36 GMT.
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.
S&P Global Market Intelligence Short Selling Activity © S&P Global Market Intelligence. All rights reserved.
Although S&P Global Market Intelligence has made every effort to ensure this data is correct, nevertheless no guarantee is given to the accuracy or completeness. Any opinions or estimates expressed herein are those of S&P Global Market Intelligence on the date of preparation and are subject to change without notice; however no such opinions or estimates constitute legal, investment or other advice. You must therefore seek independent legal, investment or other appropriate advice from a suitably qualified and/or authorised and regulated advisor prior to making any legal, investment or other decision. This is intended for information purposes only and is not intended as an offer or recommendation to buy, sell or otherwise deal in securities.